Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

Remuzzi G, Benigni A, Remuzzi A.

J Clin Invest. 2006 Feb;116(2):288-96. Review.

2.

Progression, Remission and Regression of Chronic Renal Diseases.

Cortinovis M, Ruggenenti P, Remuzzi G.

Nephron. 2016;134(1):20-4. doi: 10.1159/000445844. Epub 2016 Apr 21. Review.

3.

Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.

Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.

Am J Kidney Dis. 2000 Jun;35(6):1155-65.

PMID:
10845831
4.

Endothelin antagonists and renal protection.

Benigni A, Perico N, Remuzzi G.

J Cardiovasc Pharmacol. 2000;35(4 Suppl 2):S75-78. Review.

PMID:
10976787
5.

Proteinuria: detection and role in native renal disease progression.

Gorriz JL, Martinez-Castelao A.

Transplant Rev (Orlando). 2012 Jan;26(1):3-13. doi: 10.1016/j.trre.2011.10.002. Review.

PMID:
22137726
6.
7.

Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration.

Zoja C, Abbate M, Remuzzi G.

Nephrol Dial Transplant. 2015 May;30(5):706-12. doi: 10.1093/ndt/gfu261. Epub 2014 Aug 2. Review.

PMID:
25087196
8.

The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis.

Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH.

Ann Intern Med. 1996 Apr 1;124(7):627-32.

PMID:
8607590
9.

Proteinuria predicting outcome in renal disease: nondiabetic nephropathies (REIN).

Remuzzi G, Chiurchiu C, Ruggenenti P.

Kidney Int Suppl. 2004 Nov;(92):S90-6. Review.

10.

Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.

Steinke JM, Mauer M; International Diabetic Nephropathy Study Group.

Pediatr Endocrinol Rev. 2008 Aug;5 Suppl 4:958-63. Review.

PMID:
18806710
11.

Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies.

Wong TY, Choi PC, Szeto CC, To KF, Tang NL, Chan AW, Li PK, Lai FM.

Diabetes Care. 2002 May;25(5):900-5.

PMID:
11978688
12.

Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.

Zoja C, Garcia PB, Rota C, Conti S, Gagliardini E, Corna D, Zanchi C, Bigini P, Benigni A, Remuzzi G, Morigi M.

Am J Physiol Renal Physiol. 2012 Nov 1;303(9):F1370-81. doi: 10.1152/ajprenal.00057.2012. Epub 2012 Sep 5.

13.

Obesity and chronic kidney disease.

Eknoyan G.

Nefrologia. 2011;31(4):397-403. doi: 10.3265/Nefrologia.pre2011.May.10963. Epub 2011 May 30. Review.

14.

The nephropathy of non-insulin-dependent diabetes: predictors of outcome relative to diverse patterns of renal injury.

Ruggenenti P, Gambara V, Perna A, Bertani T, Remuzzi G.

J Am Soc Nephrol. 1998 Dec;9(12):2336-43.

15.

Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analyses.

Chiurchiu C, Remuzzi G, Ruggenenti P.

J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S58-63. Review.

16.

Characteristics of progressive renal disease.

Ots M, Pechter U, Tamm A.

Clin Chim Acta. 2000 Jul;297(1-2):29-41. Review.

PMID:
10841906
17.

[Mechanisms causing chronic renal injury in kidney disease and their possible reversibility].

Bussolati B, Collino F, Camussi G.

G Ital Nefrol. 2008 Nov-Dec;25 Suppl 44:S3-S10. Italian.

PMID:
19048579
18.

Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury.

Remuzzi A, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, Remuzzi G.

Lab Invest. 1992 Nov;67(5):572-9.

PMID:
1434536
19.

Proteinuria and progression of renal disease: therapeutic implications.

Gansevoort RT, Navis GJ, Wapstra FH, de Jong PE, de Zeeuw D.

Curr Opin Nephrol Hypertens. 1997 Mar;6(2):133-40. Review.

PMID:
9146974
20.

Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels.

Pugliese G, Pricci F, Pesce C, Romeo G, Lenti E, Caltabiano V, Vetri M, Purrello F, Di Mario U.

Diabetes. 1997 Jul;46(7):1198-206.

PMID:
9200656

Supplemental Content

Support Center